{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T23:14:22Z","timestamp":1790378062199,"version":"4.1.0"},"reference-count":62,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T00:00:00Z","timestamp":1524787200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008725","name":"Agencia Nacional de Investigaci\u00f3n e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["Fondo Mar\u00eda Vi\u00f1as 103488"],"award-info":[{"award-number":["Fondo Mar\u00eda Vi\u00f1as 103488"]}],"id":[{"id":"10.13039\/100008725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006049","name":"Comisi\u00f3n Sectorial de Investigaci\u00f3n Cient\u00edfica","doi-asserted-by":"publisher","award":["Grupos I+D 981"],"award-info":[{"award-number":["Grupos I+D 981"]}],"id":[{"id":"10.13039\/501100006049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"DOI":"10.3389\/fphar.2018.00374","type":"journal-article","created":{"date-parts":[[2018,4,27]],"date-time":"2018-04-27T08:36:40Z","timestamp":1524818200000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":29,"title":["Ibogaine Acute Administration in Rats Promotes Wakefulness, Long-Lasting REM Sleep Suppression, and a Distinctive Motor Profile"],"prefix":"10.3389","volume":"9","author":[{"given":"Joaqu\u00edn","family":"Gonz\u00e1lez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 P.","family":"Prieto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mat\u00edas","family":"Cavelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luciana","family":"Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandra","family":"Mondino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Pazos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Seoane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Carrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Scorza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Torterolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,4,27]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/105504999305848","article-title":"Treatment of acute opioid withdrawal with ibogaine.","volume":"8","author":"Alper","year":"1999","journal-title":"Am. J. Addict."},{"key":"B2","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0006-8993(96)00938-9","article-title":"Modulation of morphine-induced antinociception by ibogaine and noribogaine.","volume":"741","author":"Bagal","year":"1996","journal-title":"Brain Res."},{"key":"B3","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/0091-3057(90)90046-K","article-title":"Effects of apomorphine on novelty-induced place preference behavior in rats.","volume":"37","author":"Bardo","year":"1990","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B4","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0099-9598(01)56009-5","article-title":"Comparative neuropharmacology of ibogaine and its O-desmethyl metabolite, noribogaine.","volume":"56","author":"Baumann","year":"","journal-title":"Alkaloids Chem. Biol."},{"key":"B5","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S0022-3565(24)29567-7","article-title":"In vivo neurobiological effects of ibogaine and its O-desmethyl metabolite, 12-hydroxyibogamine (noribogaine), in rats.","volume":"297","author":"Baumann","year":"","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"B6","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1016\/0028-3908(77)90117-4","article-title":"&quotWet-dog" shake behaviour in the rat: a possible quantitative model of central 5-hydroxytryptamine activity.","volume":"16","author":"Bedard","year":"1977","journal-title":"Neuropharmacology"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.peptides.2012.10.005","article-title":"Microinjection of melanin concentrating hormone into the lateral preoptic area promotes non-REM sleep in the rat.","volume":"39","author":"Benedetto","year":"2013","journal-title":"Peptides"},{"key":"B8","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1080\/00952990.2017.1320802","article-title":"Treatment of opioid use disorder with ibogaine: detoxification and drug use outcomes.","volume":"44","author":"Brown","year":"2017","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"B9","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0014-2999(93)90212-Z","article-title":"Inhibitory effects of ibogaine on cocaine self-administration in rats.","volume":"241","author":"Cappendijk","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1111\/ejn.12143","article-title":"Coherent neocortical 40-Hz oscillations are not present during REM sleep.","volume":"37","author":"Castro","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"B11","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.bbr.2014.12.050","article-title":"Coherent neocortical gamma oscillations decrease during REM sleep in the rat.","volume":"281","author":"Cavelli","year":"2015","journal-title":"Behav. Brain Res."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15761\/TBR.1000115","article-title":"Translational brain rhythmicity absence of EEG gamma coherence in a local activated cortical state: a conserved trait of REM sleep.","volume":"2","author":"Cavelli","year":"","journal-title":"Transl. Brain Rhythm."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/ejn.13718","article-title":"Power and coherence of cortical high-frequency oscillations during wakefulness and sleep.","author":"Cavelli","year":"","journal-title":"Eur. J. Neurosci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/BF00401509","article-title":"A possible correlation between drug-induced hallucinations in man and a behavioural response in mice.","volume":"11","author":"Corne","year":"1967","journal-title":"Psychopharmacologia"},{"key":"B15","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0370-4475(80)80027-X","article-title":"Modifications de l\u2019equilibre veille-sommeil du chat par la tabernanthine et oueloues-uns de ses derives.","volume":"1","author":"Da Costa","year":"1980","journal-title":"Rev. Electroenc\u00e9phalogr. Neurophysiol. Clin."},{"key":"B16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/S0370-4475(81)80046-9","article-title":"Le retour du sommeil chez le chat pretraite par le p-chlorophenoxyacetate de tabernanthine (SAD 103).","volume":"11","author":"Da Costa-Rochette","year":"1981","journal-title":"Rev. Electroenc\u00e9phalogr. Neurophysiol. Clin."},{"key":"B17","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/0006-8993(92)90661-R","article-title":"Mechanisms of action of ibogaine and harmaline congeners based on radioligand binding studies.","volume":"571","author":"Deecher","year":"1992","journal-title":"Brain Res."},{"key":"B18","first-page":"402","article-title":"Alterations in sleep-wakefulness cycle in rats following treatment with (+)-lysergic acid diethylamide (LSD-25).","volume":"41","author":"Depoortere","year":"1971","journal-title":"Br. J. Pharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/0304-3940(80)90062-2","article-title":"Mesolimbic and mesocortical dopaminergic neurons are necessary for normal exploratory behavior in rats.","volume":"17","author":"Fink","year":"1980","journal-title":"Neurosci. Lett."},{"key":"B20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/0091-3057(86)90266-2","article-title":"Multivariate assessment of locomotor behavior: pharmacological and behavioral analyses.","volume":"25","author":"Geyer","year":"1986","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B21","first-page":"509","article-title":"Do classical hallucinogens act as 5-HT2 agonists or antagonists?","volume":"3","author":"Glennon","year":"1990","journal-title":"Neuropsychopharmacology"},{"key":"B22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/0006-8993(94)90948-2","article-title":"Effects of iboga alkaloids on morphine and cocaine self-administration in rats: relationship to tremorigenic effects and to effects on dopamine release in nucleus accumbens and striatum.","volume":"657","author":"Glick","year":"1994","journal-title":"Brain Res."},{"key":"B23","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1527-3458.1999.tb00084.x","article-title":"( \u00b1 )-18-Methoxycoronaridine: a novel iboga alkaloid congener having potential anti-addictive efficacy.","volume":"5","author":"Glick","year":"1999","journal-title":"CNS Drug Rev."},{"key":"B24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s002130050716","article-title":"18-Methoxycoronardine attenuates nicotine-induced dopamine release and nicotine preferences in rats.","volume":"139","author":"Glick","year":"1998","journal-title":"Psychopharmacology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/0028-3908(92)90089-8","article-title":"Effects of ibogaine on acute signs of morphine withdrawal in rats: independence from tremor.","volume":"31","author":"Glick","year":"1992","journal-title":"Neuropharmacology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/0014-2999(91)90474-5","article-title":"Effects and aftereffects of ibogaine on morphine self-administration in rats.","volume":"195","author":"Glick","year":"1991","journal-title":"Eur. J. Pharmacol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbr.2013.08.045","article-title":"Animal models of the serotonin syndrome: a systematic review.","volume":"256","author":"Haberzettl","year":"2013","journal-title":"Behav. Brain Res."},{"key":"B28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.vascn.2014.07.003","article-title":"Role of 5-HT1A- and 5-HT2A receptors for the murine model of the serotonin syndrome.","volume":"70","author":"Haberzettl","year":"2014","journal-title":"J. Pharmacol. Toxicol. Methods"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1177\/0269881110388326","article-title":"Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice.","volume":"25","author":"Halberstadt","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/S0091-3057(97)00451-6","article-title":"Behavioral and biochemical evidence for a nonessential 5-HT2A component of the ibogaine-induced discriminative stimulus.","volume":"59","author":"Helsley","year":"1998","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B31","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0091-3057(94)00367-R","article-title":"Effects of ibogaine on sensory-motor function, activity, and spatial learning in rats.","volume":"51","author":"Kesner","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-3-319-49712-9_2","article-title":"\u201cThe Iboga Alkaloids.","volume":"105","author":"Lavaud","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"B33","first-page":"16","article-title":"ibogaine in the treatment of chemical dependence disorders: clinical perspectives.","volume":"5","author":"Lotsof","year":"1995","journal-title":"Bull. Multidiscip. Assoc. Psychedelic Stud."},{"key":"B34","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/j.1749-6632.2000.tb05213.x","article-title":"Ibogaine: complex pharmacokinetics, concerns for safety, and preliminary efficacy measures.","volume":"914","author":"Mash","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1017\/S1461145704004511","article-title":"A study of the brain structures involved in the acute effects of fluoxetine on REM sleep in the rat.","volume":"8","author":"Monti","year":"2005","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ejphar.2006.09.027","article-title":"Effects of the serotonin 5-HT2A\/2C receptor agonist DOI and of the selective 5-HT2A or 5-HT2C receptor antagonists EMD 281014 and SB-243213, respectively, on sleep and waking in the rat.","volume":"553","author":"Monti","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.pnpbp.2014.09.003","article-title":"Increased REM sleep after intra-locus coeruleus nucleus microinjection of melanin-concentrating hormone (MCH) in the rat.","volume":"56","author":"Monti","year":"2015","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"B38","doi-asserted-by":"publisher","author":"Monti","year":"2018","DOI":"10.1007\/978-3-319-70474-6_13"},{"key":"B39","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.smrv.2012.10.002","article-title":"Melanin-concentrating hormone control of sleep\u2013wake behavior.","volume":"17","author":"Monti","year":"2013","journal-title":"Sleep Med. Rev."},{"key":"B40","author":"Naranjo","year":"1973","journal-title":"The Healing Journey."},{"key":"B41","author":"Naranjo","year":"2016","journal-title":"Exploraciones Psicod\u00e9licas: Para la Transformacio\u00ecn Colectiva de la Conciencia."},{"key":"B42","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1124\/pr.115.011478","article-title":"Psychedelics.","volume":"68","author":"Nichols","year":"2016","journal-title":"Pharmacol. Rev."},{"key":"B43","article-title":"Use of ibogaine in reducing excitotoxic brain damage","author":"Olney","year":"1995"},{"key":"B44","article-title":"Use of ibogaine for treating neuropathic pain","author":"Olney","year":"1997"},{"key":"B45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF01185522","article-title":"Influence of some monoamine oxidase inhibitors on the sleep-wakefulness cycle of the cat.","volume":"18","author":"Oniani","year":"1988","journal-title":"Neurosci. Behav. Physiol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.smrv.2012.11.001","article-title":"REM sleep dysregulation in depression: state of the art.","volume":"17","author":"Palagini","year":"2012","journal-title":"Sleep Med. Rev."},{"key":"B47","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0091-3057(96)00383-8","article-title":"Sex differences in ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain levels and metabolism.","volume":"57","author":"Pearl","year":"1997","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B48","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/BF02860623","article-title":"Tabernanthe iboga: an African narcotic plant of social importance.","volume":"23","author":"Pope","year":"1969","journal-title":"Econ. Bot."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1021\/jo00087a037","article-title":"Abbreviated ibogaine congeners. Synthesis and reactions of tropan-3-yl-2- and -3-indoles. Investigation of an unusual isomerization of 2-substituted indoles using computational and spectroscopic techniques.","volume":"59","author":"Repke","year":"1994","journal-title":"J. Org. Chem."},{"key":"B50","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/BF00170831","article-title":"(+\/-)-1-(2,5-Dimethoxy-4-ethylthiophenyl)-2-aminopropane (ALEPH-2), a novel putative anxiolytic agent lacking affinity for benzodiazepine sites and serotonin-1A receptors.","volume":"354","author":"Reyes-Parada","year":"1996","journal-title":"Naunyn. Schmiedebergs. Arch. Pharmacol."},{"key":"B51","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/0091-3057(95)00152-M","article-title":"Attenuation of alcohol intake by ibogaine in three strains of alcohol-preferring rats.","volume":"52","author":"Rezvani","year":"1995","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B52","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1177\/0269881114552713","article-title":"Treating drug dependence with the aid of ibogaine: a retrospective study.","volume":"28","author":"Schenberg","year":"2014","journal-title":"J. Psychopharmacol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1111\/j.1749-6632.1957.tb40765.x","article-title":"Neuropharmacological studies on ibogaine, an indole alkaloid with central-stimulant properties.","volume":"66","author":"Schneider","year":"1957","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B54","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1016\/0091-3057(89)90044-0","article-title":"Acute and subchronic effects of methylenedioxymethamphetamine [( + )MDMA] on locomotion and serotonin syndrome behavior in the rat.","volume":"32","author":"Spanos","year":"1989","journal-title":"Pharmacol. Biochem. Behav. U.S.A."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/BF02805969","article-title":"Pharmacological screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole alkaloid ibogaine.","volume":"127","author":"Staley","year":"1996","journal-title":"Psychopharmacology"},{"key":"B56","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/BF02245936","article-title":"Receptor binding profile suggests multiple mechanisms of action are responsible for ibogaine\u2019s putative anti-addictive activity.","volume":"118","author":"Sweetnam","year":"1995","journal-title":"Psychopharmacology"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2011.00014","article-title":"Melanin-concentrating hormone: a new sleep factor?","volume":"2","author":"Torterolo","year":"2011","journal-title":"Front. Neurol."},{"key":"B58","doi-asserted-by":"crossref","DOI":"10.1201\/9781315366340-2","article-title":"\u201cNeuroanatomy and neuropharmacology of sleep and wakefulness,\u201d in","author":"Torterolo","year":"2016","journal-title":"Synopsis of Sleep Medicine"},{"key":"B59","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/S0006-8993(98)00527-7","article-title":"Acute iboga alkaloid effects on extracellular serotonin (5-HT) levels in nucleus accumbens and striatum in rats.","volume":"800","author":"Wei","year":"1998","journal-title":"Brain Res."},{"key":"B60","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0361-9230(99)00053-2","article-title":"The effects of ibogaine on dopamine and serotonin transport in rat brain synaptosomes.","volume":"48","author":"Wells","year":"1999","journal-title":"Brain Res. Bull."},{"key":"B61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1556\/2054.01.2017.005","article-title":"Detoxification from methadone using low, repeated, and increasing doses of ibogaine: a case report.","volume":"1","author":"Wilkins","year":"2017","journal-title":"J. Psychedelic Stud."},{"key":"B62","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/0014-2999(75)90278-2","article-title":"Behavioral effects of 2,5-dimethoxy-4-methylamphetamine (DOM) in rats and mice.","volume":"32","author":"Yamamoto","year":"1975","journal-title":"Eur. J. Pharmacol."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00374\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T19:53:15Z","timestamp":1751572395000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/article\/10.3389\/fphar.2018.00374\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,27]]},"references-count":62,"alternative-id":["10.3389\/fphar.2018.00374"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2018.00374","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,27]]},"article-number":"374"}}